{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T18:17:08Z","timestamp":1769883428650,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invasive bacterial infections are frequent causes of hospitalization among people who use opioids. We evaluated the association between inpatient administration of medication for opioid use disorder with one-year all-cause mortality in patients hospitalized with invasive bacterial infections.<\/jats:p>","DOI":"10.1093\/ofid\/ofaf061","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T16:32:56Z","timestamp":1738600376000},"source":"Crossref","is-referenced-by-count":1,"title":["Association Between Inpatient Medication Treatment for Opioid Use Disorder and Reduced One-Year All-Cause Mortality in Patients With Invasive Bacterial Infections"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8142-7244","authenticated-orcid":false,"given":"Nicholas J","family":"Blair","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Columbia University , New York, New York ,","place":["USA"]},{"name":"Division of Internal Medicine, New York\u2013Presbyterian Hospital , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Kopp","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Columbia University , New York, New York ,","place":["USA"]},{"name":"Division of Internal Medicine, New York\u2013Presbyterian Hospital , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-440X","authenticated-orcid":false,"given":"Christine","family":"Kubin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Columbia University , New York, New York ,","place":["USA"]},{"name":"Division of Internal Medicine, New York\u2013Presbyterian Hospital , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Cotton","sequence":"additional","affiliation":[{"name":"College of Physicians and Surgeons, Columbia University , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9056","authenticated-orcid":false,"given":"Michael T","family":"Yin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Columbia University , New York, New York ,","place":["USA"]},{"name":"Division of Internal Medicine, New York\u2013Presbyterian Hospital , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Scherer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Columbia University , New York, New York ,","place":["USA"]},{"name":"Division of Internal Medicine, New York\u2013Presbyterian Hospital , New York, New York ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2025031112343011900_ofaf061-B1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mcna.2021.08.006","article-title":"Infectious complications of injection drug use","volume":"106","author":"Marks","year":"2022","journal-title":"Med Clin North Am"},{"key":"2025031112343011900_ofaf061-B2","doi-asserted-by":"crossref","first-page":"e031589","DOI":"10.1161\/JAHA.123.031589","article-title":"Trends in infective endocarditis mortality in the United States: 1999 to 2020: a cause for alarm","volume":"12","author":"Chobufo","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"2025031112343011900_ofaf061-B3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41380-022-01903-1","article-title":"Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US","volume":"28","author":"Wang","year":"2023","journal-title":"Mol Psychiatry"},{"key":"2025031112343011900_ofaf061-B4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/cid\/ciad119","article-title":"Real-world application of oral therapy for infective endocarditis: a multicenter, retrospective, cohort study","volume":"77","author":"Freling","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025031112343011900_ofaf061-B5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jamainternmed.2020.0555","article-title":"Evaluation of a paradigm shift from intravenous antibiotics to oral step-down therapy for the treatment of infective endocarditis: a narrative review","volume":"180","author":"Spellberg","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2025031112343011900_ofaf061-B6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0002-9343(96)00070-8","article-title":"Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy","volume":"101","author":"Heldman","year":"1996","journal-title":"Am J Med"},{"key":"2025031112343011900_ofaf061-B7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.amjmed.2021.10.007","article-title":"Oral is the new IV. Challenging decades of blood and bone infection dogma: a systematic review","volume":"135","author":"Wald-Dickler","year":"2022","journal-title":"Am J Med"},{"key":"2025031112343011900_ofaf061-B8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial oral versus intravenous antibiotic treatment of endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N Engl J Med"},{"key":"2025031112343011900_ofaf061-B9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"2025031112343011900_ofaf061-B10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ADM.0000000000000693","article-title":"Rejection of patients with opioid use disorder referred for post-acute medical care before and after an anti-discrimination settlement in Massachusetts","volume":"15","author":"Kimmel","year":"2021","journal-title":"J Addict Med"},{"key":"2025031112343011900_ofaf061-B11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/s12913-020-05670-z","article-title":"Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada","volume":"20","author":"Kendall","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"9","key":"2025031112343011900_ofaf061-B12","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"2025031112343011900_ofaf061-B13","doi-asserted-by":"crossref","first-page":"108207","DOI":"10.1016\/j.drugalcdep.2020.108207","article-title":"Impact of medications for opioid use disorder among persons hospitalized for drug use\u2013associated skin and soft tissue infections","volume":"215","author":"Barocas","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"2025031112343011900_ofaf061-B14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciaa062","article-title":"Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis","volume":"72","author":"Barocas","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025031112343011900_ofaf061-B15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1176\/appi.ajp.23180008","article-title":"Treatment of opioid use disorder in the general hospital","volume":"180","author":"Funk","year":"2023","journal-title":"Am J Psychiatry"},{"key":"2025031112343011900_ofaf061-B16","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/jhm.12908","article-title":"Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: a systematic review of existing guidelines","volume":"17","author":"Calcaterra","year":"2022","journal-title":"J Hosp Med"},{"issue":"Suppl 5","key":"2025031112343011900_ofaf061-B17","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1093\/infdis\/jiz516","article-title":"A comparison of medication for opioid use disorder treatment strategies for persons who inject drugs with invasive bacterial and fungal infections","volume":"222","author":"Marks","year":"2020","journal-title":"J Infect Dis"},{"key":"2025031112343011900_ofaf061-B18","doi-asserted-by":"crossref","first-page":"209298","DOI":"10.1016\/j.josat.2024.209298","article-title":"Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: a matched cohort study","volume":"160","author":"Robertson","year":"2024","journal-title":"J Subst Use Addict Treat"},{"key":"2025031112343011900_ofaf061-B19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ADM.0000000000000725","article-title":"Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection","volume":"15","author":"Nolan","year":"2021","journal-title":"J Addict Med"},{"key":"2025031112343011900_ofaf061-B20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/ADM.0000000000000572","article-title":"Long-term outcomes of injection drug\u2013related infective endocarditis among people who inject drugs","volume":"14","author":"Suzuki","year":"2020","journal-title":"J Addict Med"},{"key":"2025031112343011900_ofaf061-B21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","article-title":"Racial inequality in receipt of medications for opioid use disorder","volume":"388","author":"Barnett","year":"2023","journal-title":"N Engl J Med"},{"key":"2025031112343011900_ofaf061-B22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/cid\/ciad271","article-title":"The 2023 Duke\u2013International Society for Cardiovascular Infectious Diseases criteria for infective endocarditis: updating the modified Duke criteria","volume":"77","author":"Fowler","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025031112343011900_ofaf061-B23","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12889-023-15875-6","article-title":"Housing instability and cardiometabolic health in the United States: a narrative review of the literature","volume":"23","author":"Gu","year":"2023","journal-title":"BMC Public Health"},{"key":"2025031112343011900_ofaf061-B24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/JNC.0000000000000314","article-title":"Characteristics of adults with diagnosed HIV who experienced housing instability: findings from the Centers for Disease Control and Prevention medical monitoring project, United States, 2018","volume":"33","author":"Marcus","year":"2022","journal-title":"J Assoc Nurses AIDS Care"},{"key":"2025031112343011900_ofaf061-B25","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1111\/add.15393","article-title":"Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014\u201318","volume":"116","author":"Jo","year":"2021","journal-title":"Addiction"},{"key":"2025031112343011900_ofaf061-B26","doi-asserted-by":"crossref","first-page":"100114","DOI":"10.1016\/j.dadr.2022.100114","article-title":"Initiation of medication for opioid use disorder across a health system: a retrospective analysis of patient characteristics and inpatient outcomes","volume":"5","author":"O\u2019Rourke","year":"2022","journal-title":"Drug Alcohol Depend Rep"},{"key":"2025031112343011900_ofaf061-B27","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0000000000003629","article-title":"Undertreatment of opioid use disorder in patients hospitalized with injection drug use\u2013associated infections","volume":"37","author":"Rosenthal","year":"2023","journal-title":"AIDS"},{"key":"2025031112343011900_ofaf061-B28","doi-asserted-by":"crossref","first-page":"21501319221112272","DOI":"10.1177\/21501319221112272","article-title":"Buprenorphine waiver attitudes among primary care providers","volume":"13","author":"Lai","year":"2022","journal-title":"J Prim Care Community Health"},{"key":"2025031112343011900_ofaf061-B29","doi-asserted-by":"crossref","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the United States","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025031112343011900_ofaf061-B30","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cid\/ciz869","article-title":"Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery","volume":"71","author":"Straw","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025031112343011900_ofaf061-B31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1053\/j.semtcvs.2020.11.031","article-title":"Cardiac surgeons\u2019 treatment approaches for infective endocarditis based on patients\u2019 substance use history","volume":"33","author":"Nguemeni Tiako","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2025031112343011900_ofaf061-B32","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s11606-024-08670-5","article-title":"Post-hospitalization care transition strategies for patients with substance use disorders: a narrative review and taxonomy","volume":"39","author":"Incze","year":"2024","journal-title":"J Gen Intern Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf061\/61741709\/ofaf061.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/3\/ofaf061\/61741709\/ofaf061.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/3\/ofaf061\/61741709\/ofaf061.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T13:29:47Z","timestamp":1741699787000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf061\/7997396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf061","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2025,2,3]]},"article-number":"ofaf061"}}